Chair: Sarah Price
Excessive weight gain before and during GDM treatment – what is the impact? (#39)
11:45 AM
Could we obtain better “value” from the pregnancy oral glucose tolerance test (OGTT) in diagnosis of gestational diabetes mellitus (GDM)? A secondary analysis using the Australian HAPO data. (#40)
11:55 AM
A NOVEL CALCULATOR TO DETERMINE THE RISK OF INSULIN THERAPY IN WOMEN WITH GDM (#41)
12:05 PM
HAVE THE NEW ADIPS GDM CRITERIA RESULTED IN A CHANGE IN THE CLINIC POPULATION AND/OR MATERNAL AND NEONATAL OUTCOMES? (#42)
12:15 PM
Are the changes in diagnostic criteria for Gestational Diabetes Mellitus reflected in pregnancy outcomes: a retrospective assessment? (#43)
12:20 PM
What is the relationship between pre-pregnancy BMI and fasting and post load OGTT values in Pregnancy? (#44)
12:25 PM
Biomarkers and GDM risk prediction (#45)
12:30 PM
Seasonality, temperature and pregnancy oral glucose tolerance test results in Australia (#46)
12:35 PM
A Case of Lactation Ketoacidosis following a Low Carbohydrate (Ketogenic) diet (#47)
12:40 PM
Factors associated with neonatal Hyperbilirubinaemia in Gestational Diabetes Mellitus (#48)
12:45 PM
Maternal glycaemic biomarkers associated with birthweight and ‘large-for-gestational-age’ infants in pregnancies affected by diabetes (#49)
12:50 PM
Hyperglycaemia associated with antenatal corticosteroid use (#50)
12:55 PM